2026-05-22 • The Psychedelic Blog (Substack)

7 Lessons From 7 Years With Psychedelics

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

External link. We are not responsible for the content.

Read more ↗

More From The Psychedelic Blog (Substack)

2026-08-23 • The Psychedelic Blog (Substack)

Global Altered States: Anytown, USA

This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.

2026-08-21 • The Psychedelic Blog (Substack)

5 Psychedelic Stories You Should Know This Week

Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...

2026-08-16 • The Psychedelic Blog (Substack)

The Psychedelic Future We Were Promised

This Week's Sunday Insider: Why the Psychedelic Future Never Arrived.

Latest News

2026-08-27 • PsyMed Ventures

Why Most Drugs Fail, and Why Virtual Tissue Models Beat Virtual Cell Models

Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness!

2026-08-27 • Microdose (industry)

Ibogaine’s Momentum Is Real. So Is the Safety Gap Nobody’s Solving.

Recent reporting, has documented a string of serious adverse events at overseas psychedelic clinics such as cardiac d...

2026-08-26 • DoubleBlind Magazine

Was Carlos Castaneda Among the First Psychedelic Grifters?

Author Carlos Castaneda built a fortune on a fabricated Indigenous lineage. A new biography shows how his blueprint s...

2026-08-25 • MAPS

University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science

Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...

2026-08-25 • Psychedelics Today

Who Gets to Heal?

A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether...

2026-08-25 • Psychedelics Today

Weekly Psychedelic Policy Briefing: August 23, 2026

Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increa...